Cramer says Regeneron stock is the best bet among health-care companies fighting Covid

Jim Cramer
Scott Mlyn | CNBC

The stock of health-care company Regeneron could rise as its antibody treatment sees wider use in the fight against Covid-19, CNBC's Jim Cramer said Monday.